Quidel Buying Diagnostic Hybrids for $130 Million
Quidel Corp. (Nasdaq: QDEL) has agreed to acquire Diagnostic Hybrids, an Athens, Ohio-based maker of direct fluorescent in vitro diagnostic assays. The deal is valued at approximately $130 million in cash. Diagnostic Hybrids raised around $10 million in 2004 from Summit Partners.
11 January 2010•5 mins read
